How many insider trades does FilingIQ track for TNYA?

FilingIQ tracks 116 Form 4 insider transactions for TNYA (Tenaya Therapeutics, Inc.), covering filings from Aug 3, 2021 onwards. 17 of those were filed in the last 90 days.

Are TNYA insiders net buyers or net sellers?

Across the full Form 4 history for TNYA, 20 transactions (17%) were open-market purchases and 65 (56%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TNYA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TNYA in?

Tenaya Therapeutics, Inc. (TNYA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $133.80M.

TNYA insider trading

Healthcare

Tenaya Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

116

Last 90 days

Buys / sells

17% / 56%

Market cap

$133.80M

About Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company's lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in phase 2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in phase 1 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. The company develops its products through gene editing, cellular regeneration, gene silencing, and gene addition. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Company website: www.tenayatherapeutics.com

TNYA insider activity at a glance

FilingIQ has scored 116 insider transactions for TNYA since Aug 3, 2021. The most recent filing in our index is dated Feb 25, 2026.

Across the full history, 20 open-market purchases and 65 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TNYA insider trades is 55.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TNYA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding TNYA

Casdin Capital, LLC

$20.87M · 1.6% of AUM

Euclidean Capital LLC

$2.59M · 0.6% of AUM

Frequently asked

How many insider trades does FilingIQ track for TNYA?: FilingIQ tracks 116 Form 4 insider transactions for TNYA (Tenaya Therapeutics, Inc.), covering filings from Aug 3, 2021 onwards. 17 of those were filed in the last 90 days.
Are TNYA insiders net buyers or net sellers?: Across the full Form 4 history for TNYA, 20 transactions (17%) were open-market purchases and 65 (56%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TNYA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TNYA in?: Tenaya Therapeutics, Inc. (TNYA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $133.80M.

Methodology & sources

Every TNYA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.